Segui
Francesca Giulimondi
Francesca Giulimondi
Email verificata su uniroma1.it
Titolo
Citata da
Citata da
Anno
Interplay of protein corona and immune cells controls blood residency of liposomes
F Giulimondi, L Digiacomo, D Pozzi, S Palchetti, E Vulpis, AL Capriotti, ...
Nature communications 10 (1), 3686, 2019
1842019
Identification of a novel chalcone derivative that inhibits Notch signaling in T-cell acute lymphoblastic leukemia
M Mori, L Tottone, D Quaglio, N Zhdanovskaya, C Ingallina, M Fusto, ...
Scientific Reports 7 (1), 1-13, 2017
532017
Converting the personalized biomolecular corona of graphene oxide nanoflakes into a high-throughput diagnostic test for early cancer detection
M Papi, V Palmieri, L Digiacomo, F Giulimondi, S Palchetti, G Ciasca, ...
Nanoscale 11 (32), 15339-15346, 2019
442019
The biomolecular corona of gold nanoparticles in a controlled microfluidic environment
L Digiacomo, S Palchetti, F Giulimondi, D Pozzi, RZ Chiozzi, AL Capriotti, ...
Lab on a Chip 19 (15), 2557-2567, 2019
432019
Microfluidic formulation of DNA-loaded multicomponent lipid nanoparticles for gene delivery
E Quagliarini, S Renzi, L Digiacomo, F Giulimondi, B Sartori, H Amenitsch, ...
Pharmaceutics 13 (8), 1292, 2021
322021
Opsonin-Deficient Nucleoproteic Corona Endows UnPEGylated Liposomes with Stealth Properties In Vivo
F Giulimondi, E Vulpis, L Digiacomo, MV Giuli, A Mancusi, AL Capriotti, ...
ACS nano 16 (2), 2088-2100, 2022
302022
A mechanistic explanation of the inhibitory role of the protein corona on liposomal gene expression
S Palchetti, L Digiacomo, F Giulimondi, D Pozzi, G Peruzzi, G Ferri, ...
Biochimica et Biophysica Acta (BBA)-Biomembranes 1862 (3), 183159, 2020
172020
Effect of molecular crowding on the biological identity of liposomes: an overlooked factor at the bio-nano interface
L Digiacomo, F Giulimondi, M Mahmoudi, G Caracciolo
Nanoscale Advances 1 (7), 2518-2522, 2019
172019
Inhibiting the growth of 3D brain cancer models with bio-coronated liposomal temozolomide
G Perini, F Giulimondi, V Palmieri, A Augello, L Digiacomo, E Quagliarini, ...
Pharmaceutics 13 (3), 378, 2021
152021
The possible role of sex as an important factor in development and administration of lipid nanomedicine-based COVID-19 vaccine
E Vulpis, F Giulimondi, L Digiacomo, A Zingoni, R Safavi-Sohi, S Sharifi, ...
Molecular Pharmaceutics 18 (6), 2448-2453, 2021
142021
Optimal centrifugal isolating of liposome–protein complexes from human plasma
L Digiacomo, F Giulimondi, AL Capriotti, S Piovesana, CM Montone, ...
Nanoscale Advances 3 (13), 3824-3834, 2021
132021
A proteomic study on the personalized protein corona of liposomes. Relevance for early diagnosis of pancreatic DUCTAL adenocarcinoma and biomarker detection
L Digiacomo, F Giulimondi, D Pozzi, A Coppola, V La Vaccara, D Caputo, ...
Journal of Nanotheranostics 2 (2), 82-93, 2021
122021
Efficient pancreatic cancer detection through personalized protein corona of gold nanoparticles
L Digiacomo, D Caputo, R Coppola, C Cascone, F Giulimondi, S Palchetti, ...
Biointerphases 16 (1), 011010, 2021
112021
The protein corona reduces the anticancer effect of graphene oxide in HER-2-positive cancer cells
L Cui, E Quagliarini, S Xiao, F Giulimondi, S Renzi, L Digiacomo, ...
Nanoscale Advances 4 (18), 4009-4015, 2022
62022
Author correction: interplay of protein corona and immune cells controls blood residency of liposomes
F Giulimondi, L Digiacomo, D Pozzi, S Palchetti, E Vulpis, AL Capriotti, ...
Nature Communications 11 (1), 1697, 2020
52020
In vitro and ex vivo nano-enabled immunomodulation by the protein corona
F Giulimondi, L Digiacomo, E Vulpis, L Loconte, G Ferri, F Cardarelli, ...
Nanoscale 14 (29), 10531-10539, 2022
32022
Reproducibility of Biomolecular Corona experiments: a primer for reliable results
F Giulimondi, E Quagliarini, L Digiacomo, S Renzi, V Palmieri, M Papi, ...
Particle & Particle Systems Characterization, 2200169, 2022
2022
Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia
B Botta, I Screpanti, L Tottone, N Zhdanoskaya, C Ingallina, F Giulimondi, ...
US Patent App. 17/397,509, 2021
2021
Notch inhibitors for use in the treatment of t-cell acute lymphoblastic leukemia
B Botta, I Screpanti, L Tottone, N Zhdanoskaya, C Ingallina, F Giulimondi, ...
US Patent 11,104,657, 2021
2021
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–19